HOME >> BIOLOGY >> NEWS
Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks

Of all the weapons in the bioterrorist arsenal, none is as potent as botulinum neurotoxin, which causes botulisma potentially fatal disease with symptoms that include severe paralysis of the limbs and respiratory muscles. Just 1 gram of botulinum neurotoxin, evenly dispersed and inhaled, could kill more than a million people, according to a 2001 study in the Journal of the American Medical Association. Botulinum also holds the distinction of being the only high-risk biological weapon thats approved for therapeutic and cosmetic use as the active ingredient in the widely prescribed commercial products Botox and Dysport.

Now, for the first time, scientists from Stanford University and the Medical School of Hannover in Germany have figured out how this powerful neurotoxin binds to and disables individual nerve cells. Researchers say their discovery, published in the Dec. 13 online edition of the journal Nature, could lead to new treatments for botulism, which also is caused by eating botulinum-contaminated food.

Our results could provide the basis for the rational development of preventive vaccines against botulinum neurotoxins, said study co-author Axel T. Brunger, a Howard Hughes Medical Institute (HHMI) investigator who holds professorships in four Stanford unitsthe Molecular and Cellular Physiology Department, the Neurology and Neurological Sciences Department, the Stanford Synchrotron Radiation Laboratory (SSRL) and, by courtesy, the Structural Biology Department.

Effective binding inhibitors or vaccines are urgently needed, given the concerns about the safety and scarcity of current botulism therapies, Brunger added.

3-D images

Along with the Stanford experiment, Nature simultaneously published a separate study led by scientists from the Scripps Research Institute. In both studies, scientists used a technique called X-ray crystallography to produce the first three-dimensional, atomic-scale images of botulinum neurotoxin binding t
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
831-915-0088
Stanford University
13-Dec-2006


Page: 1 2 3

Related biology news :

1. Botulism bug has few genome wrinkles
2. Botulism bug says no to nitric oxide, provides key to molecules role in human cell signaling
3. New study warns limited carbon market puts 20 percent of tropical forest at risk
4. Clones on task serve greater good, evolutionary study shows
5. Pollution causes 40 percent of deaths worldwide, study finds
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. New study suggests Concord grape juice may provide protection against breast cancer
8. Preclinical study links gene to brain aneurysm formation
9. In limiting life span, study finds booming bacteria innocent
10. Multicenter study nets new lung tumor-suppressor gene
11. MIT study: Maturity brings richer memories

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2019)... ... December 17, 2019 , ... Mitotech S.A, a Luxembourg-based clinical-stage ... its U.S. Phase 3 study VISTA-2 building on positive results of VISTA-1 clinical ... to severe Dry Eye Disease (DED). SkQ1 belongs to the class of cardiolipin ...
(Date:12/18/2019)... SEATTLE (PRWEB) , ... December 18, 2019 , ... ... higher education planning, has announced the Top 10 Master's in Biotechnology Degree Programs ... accredited colleges and universities in the nation. Each program is evaluated based on ...
(Date:12/14/2019)... ... 12, 2019 , ... Crop Enhancement Inc., an ... Jean Pougnier as chief business officer. Mr. Pougnier will lead the company’s efforts ... will position the company for maximum commercial success. As part of the expansion ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... ... a Digital World at The Fletcher School at Tufts University, is pleased to ... Foundation. The grant will be administered by Tufts University, and will help to ...
(Date:12/31/2019)... ... December 31, 2019 , ... Vici ... development lab in Maryland. Emphasis will be in expanding capabilities in ... Vici Health Sciences will be well positioned to meet the growing demand for ...
(Date:12/27/2019)... HARBOR TOWNSHIP, N.J. (PRWEB) , ... December 27, ... ... manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical ... first calendar year under new management . Following acquisition by CLJ Holdings ...
(Date:12/18/2019)... ... December 17, 2019 , ... Innovative Health, Inc. ... Electrophysiology (EP) devices since the company’s inception in 2016. This marks a record ... Johnson & Johnson company) have received 2 and 4 EP device clearances, respectively, ...
Breaking Biology Technology:
Cached News: